Success Metrics

Clinical Success Rate
93.8%

Based on 15 completed trials

Completion Rate
94%(15/16)
Active Trials
2(10%)
Results Posted
33%(5 trials)
Terminated
1(5%)

Phase Distribution

Ph phase_4
1
5%
Ph not_applicable
17
81%
Ph early_phase_1
1
5%
Ph phase_3
1
5%

Phase Distribution

1

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution20 total trials
Early Phase 1First-in-human
1(5.0%)
Phase 3Large-scale testing
1(5.0%)
Phase 4Post-market surveillance
1(5.0%)
N/ANon-phased studies
17(85.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

83.3%

15 of 18 finished

Non-Completion Rate

16.7%

3 ended early

Currently Active

2

trials recruiting

Total Trials

21

all time

Status Distribution
Active(2)
Completed(15)
Terminated(3)
Other(1)

Detailed Status

Completed15
Withdrawn2
Active, not recruiting1
Recruiting1
Terminated1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
21
Active
2
Success Rate
93.8%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (5.0%)
Phase 31 (5.0%)
Phase 41 (5.0%)
N/A17 (85.0%)

Trials by Status

active_not_recruiting15%
completed1571%
recruiting15%
withdrawn210%
terminated15%
unknown15%

Recent Activity

Clinical Trials (21)

Showing 20 of 21 trialsScroll for more
NCT03691350Early Phase 1

Bronchoscopy in Determining the Effect of E-Cigarette Smoking on Biomarkers in the Lungs

Completed
NCT03856515Not Applicable

Gender Differences in Switching From Smoking Regular Cigarettes to E-Cigarettes

Completed
NCT05703672Phase 3

Switching to E-cigarettes in Smokers Not Interested in Quitting

Recruiting
NCT04449510Not Applicable

Short-Term Cardiovascular Effects of E-Cigarettes: Influence of E-Liquid pH

Completed
NCT02294617Not Applicable

E-cigarette vs. Nicotine Inhaler Comparisons

Completed
NCT05206435Phase 4

Methadone-Maintained Smokers Switching to E-Cigarettes

Active Not Recruiting
NCT02596685Not Applicable

Effects of Electronic Cigarette Use on the Lungs

Completed
NCT03839745Not Applicable

Short-Term Cardiovascular Effects of E-Cigarettes: Influence of Device Power

Completed
NCT01935713Not Applicable

Preliminary Investigation of Novel Methods to Reduce Children's Secondhand Smoke Exposure

Completed
NCT05030194Not Applicable

Comparing Nicotine Delivery, Subjective Effects, and Sensory Experiences of Tobacco Users Using Oral Nicotine Products and Electronic Cigarettes [ZYN Study]

Completed
NCT03453385Not Applicable

Clinical Outcomes of a Nationwide, Naturalistic E-Cig Trial (CONNECT)

Completed
NCT02470754Not Applicable

Clinical Pharmacology of Electronic Cigarettes

Completed
NCT02532894Not Applicable

Effects of E-smoke on Levels of Endothelial Progenitor Cells and Microparticles in Healthy Volunteers

Completed
NCT03041493Not Applicable

Investigation of the Effects of Electronic Cigarettes on Vascular Health

Terminated
NCT03039920Not Applicable

The Effects of Electronic Cigarette Smoking on the Arterial Wall and Endothelial Glycocalyx Properties of Smokers

Unknown
NCT03379025Not Applicable

Effects of Electronic Cigarettes in Cigarette Smokers With Mild to Moderate COPD

Withdrawn
NCT02575885Not Applicable

Nicotine Delivery From Novel Non-Tobacco Electronic System in Smokers

Completed
NCT02357173Not Applicable

A Trial of E-cigarettes in Current Cigarette Smokers

Completed
NCT02433015Not Applicable

Neurophysiological and Immunological Effects of the Transition From Combustible to Electronic Cigarettes

Completed
NCT02949648

Electronic Cigarette Use and Quitting in Youth

Completed

Drug Details

Intervention Type
OTHER
Total Trials
21